Specialty code 183500000X · San Diego, CA
NPI
1912558297
Since 2019
Specialty
Specialty code 183500000X
Code 183500000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
4647 Zion Ave
San Diego, CA, 92120
Phone (619) 750-0569
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$349K
1,568 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Vishnavi P Reddy prescribed most often to Medicare patients was Metformin Hcl, with 170 prescriptions and refills. In total Vishnavi P Reddy wrote 1,568 Medicare prescriptions that cost $349K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-06-16.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Metformin Hcl Generic | 170 | 565 | 75 | $2,105 |
| Jardiance Empagliflozin | 163 | 508 | 63 | $80K |
| Atorvastatin Calcium Generic | 145 | 483 | 62 | $1,727 |
| Metformin Hcl Er Metformin Hcl | 141 | 467 | 68 | $1,347 |
| Glipizide Er Glipizide | 139 | 461 | 56 | $5,452 |
| Glipizide Generic | 117 | 389 | 52 | $1,654 |
| Ozempic Semaglutide | 83 | 84 | 17 | $61K |
| Humulin N Insulin Nph Human Isophane | 60 | 190 | 26 | $13K |
| Humulin N Kwikpen Insulin Nph Human Isophane | 53 | 155 | 26 | $17K |
| Ultra-Fine Nano Pen Needle Pen Needle, Diabetic | 52 | 114 | 15 | $1,167 |
| Victoza 2-Pak Liraglutide | 45 | 68 | 15 | $36K |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 45 | 141 | 19 | $1,446 |
| Insulin Glargine-Yfgn Generic | 41 | 124 | 25 | $7,964 |
| Liraglutide Generic | 40 | 58 | 17 | $37K |
| Simvastatin Generic | 38 | 127 | 16 | $433 |
Brand drugs: 613 claims; generic drugs: 810 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Vishnavi P Reddy were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.